Login / Signup

cIAP1-based degraders induce degradation via branched ubiquitin architectures.

Yoshino AkizukiMai MoritaYuki MoriAi Kaiho-SomaShivani DixitAkinori EndoMarie ShimogawaGosuke HayashiMikihiko NaitoAkimitsu OkamotoKeiji TanakaYasushi SaekiFumiaki Ohtake
Published in: Nature chemical biology (2022)
Targeted protein degradation through chemical hijacking of E3 ubiquitin ligases is an emerging concept in precision medicine. The ubiquitin code is a critical determinant of the fate of substrates. Although two E3s, CRL2 VHL and CRL4 CRBN , frequently assemble with proteolysis-targeting chimeras (PROTACs) to attach lysine-48 (K48)-linked ubiquitin chains, the diversity of the ubiquitin code used for chemically induced degradation is largely unknown. Here we show that the efficacy of cIAP1-targeting degraders depends on the K63-specific E2 enzyme UBE2N. UBE2N promotes degradation of cIAP1 induced by cIAP1 ligands and subsequent cancer cell apoptosis. Mechanistically, UBE2N-catalyzed K63-linked ubiquitin chains facilitate assembly of highly complex K48/K63 and K11/K48 branched ubiquitin chains, thereby recruiting p97/VCP, UCH37 and the proteasome. Degradation of neo-substrates directed by cIAP1-recruiting PROTACs also depends on UBE2N. These results reveal an unexpected role for K63-linked ubiquitin chains and UBE2N in degrader-induced proteasomal degradation and demonstrate the diversity of the ubiquitin code used for chemical hijacking.
Keyphrases
  • small molecule
  • cancer therapy
  • high glucose
  • gene expression
  • diabetic rats
  • oxidative stress
  • drug delivery
  • young adults